Page 127 - medicina-integrativa_compress

CAPÍTULO 11 TRASTORNO POR DÉFICIT DE ATENCIÓN 117

74. Harley JP, Ray RS, Tomasi L, et al: Synthetic food colors and 99. Haag M: Essential fatty acids and the brain. Can J Psychiatry 48:
hyperactivity in children: A double-blind challenge experiment. 195-203, 2003.
Pediatrics 62:978-983, 1978. 100. Neuringer M, Reisbeck S, Janowsky J: The role of omega-3 fatty
75. Swanson JM, Kinsbourne M: Food dyes impair performance of acids in visual and cognitive development: Current evidence and
hyperactive children on a laboratory learning test. Science 207: methods of assessment. J Pediatr 125:S39-S47, 1994.
1485-1487, 1980. 101. Neuringer MD, Connor WE, Lin DS, et al: Biochemical and
76. Egger J, Graham PJ, Carter CM, et al: Controlled trial of functional effects of prenatal and postnatal omega-3 fatty acid
oligoantigenic treatment in the hyperkinetic syndrome. Lancet deficiency on retina and brain in rhesus monkeys. Proc Natl Acad
1:865-869, 1985. Sci U S A 83:4021-4025, 1986.
77. Rowe KS, Rowe KJ: Synthetic food coloring and behavior: A dose- 102. Colquhoun I, Bunday S: A lack of essential fatty acids as a possible
response effect in a double-blind, placebo-controlled, cause of hyperactivity in children. Med Hypoth 7:673-679, 1981.
repeated-measures study. J Pediatr 125:691-698, 1994. 103. Francas H, Monier C, Bourre JM: Effects of dietary alpha-linolenic
78. Boris M, Mandel FS: Foods and additives are common causes of the acid deficiency on neuromuscular and cognitive functions in mice.
attention deficit hyperactive disorder in children. Ann Allergy Life Sci 57:1935-1947, 1995.
72:462-468, 1994. 104. Morale SE, Hoffman DR, Castaneda YS, et al: Duration of long-
79. Schab DW, Trinh NT: Do artificial food colors promote hyperactivity chain polyunsaturated fatty acids availability in the diet and visual
in children with hyperactive syndromes? A meta-analysis of double- acuity. Early Hum Dev 81:197-203, 2005.
blind placebo-controlled trials. J Dev Behav Pediatr 25: 423-434, 2004. 105. Williams C, Birch EE, Emmett PM, Northstone K: Avon
80. Bateman B, Warner JO, Hutchinson E, et al: The effects of a double- Longitudinal Study of Pregnancy and Childhood Study Team.
blind, placebo-controlled, artificial food colourings, and benzoate Stereoacuity at age 3.5 years in children born full-term is associated
preservative challenge on hyperactivity in a general population with prenatal and postnatal dietary factors: A report from a
sample of preschool children. Arch Dis Child 89:506-511, 2004. population-based cohort study. Am J Clin Nutr 73:316-322,
81. Pelsser LM, Buitelaar JK: Favourable effect of a standard elimination 2001.
diet on the behavior of young children with attention deficit 106. Dobbing J (ed): Developing Brain and Behaviour: The Role of Lipids
hyperactivity disorder (ADHD): A pilot study. Nederlands in Infant Formula. London, Academic Press, 1997.
Tijdschrift voor Geneeskunde 146:2543-2547, 2002. 107. Aman MG, Mitchell EA, Turbott SH: The effects of essential fatty
82. Egger J, Stolla A, McEwen LM: Controlled trial of hyposensitisation acid supplementation by Efamol in hyperactive children. J Abnormal
in children with food-induced hyperkinetic syndrome. Lancet Child Psychol 15:75-90, 1987.
339:1150-1153, 1992. 108. Arnold LE, Kleykamp D, Votolato NA, et al: Gamma linolenic acid
83. Hughes EC, Weinstein RC, Gott PS, et al: Food sensitivity in for attention-deficit hyperactivity disorder: Placebo-controlled
attention deficit disorder with hyperactivity (ADD/HA): comparison to D-amphetamine. Biol Psychiatry 25:222-228, 1989.
A procedure for differential diagnosis. Ann Allergy 49:276-280, 1982. 109. Voight RG, Llorente AM, Jensen CL, et al: A randomized, double-
84. Goldman JA, Lerman RH, Contois JH, Udall JN: Behavioral effects blind, placebo-controlled trial of docosahexanoic acid
of sucrose on preschool children. J Abnormal Child Psychol 14: supplementation in children with attention deficit/hyperactivity
565-577, 1986. disorder. J Pediatr 139:189-196, 2001.
85. Prinz RJ, Roberts WA, Hantman E: Dietary correlates of hyperactive 110. Stevens L, Zhang W, Peck L, et al: EFA supplementation in children
behavior in children. J Consult Clin Psychol 48:760-769, 1980. with inattention, hyperactivity, and other disruptive behaviors.
86. Prinz RJ, Riddle DB: Associations between nutrition and behavior in Lipids 38:1007-1021, 2003.
5-year-old children. Nutr Rev 44:151-157, 1986. 111. Richardson AJ, Puri BK: A randomized double-blind, placebo-
87. Underwood BA: Evaluating the nutritional status of individuals: controlled study of the effects of supplementation with highly
A critique of approaches. Nutr Rev 44(Suppl):213-224, 1986. unsaturated fatty acids on ADHD-related symptoms in children with
88. Jacob RA, Milne DB: Biochemical assessment of vitamins and trace specific learning difficulties. Prog Neuropsychopharmacol Biologic
metals. Nutr Support Clin Lab Med 13:371-383, 1993. Psychiatry 26:233-239, 2002.
89. Arnold LE, Pinkham SM, Votolato N: Does zinc moderate essential 112. Richardson AJ, Montgomery P: The Oxford-Durham study: A
fatty acid and amphetamine treatment of attention- randomized, controlled trial of dietary supplementation with fatty
deficit/hyperactivity disorder? J Child Adolesc Psychopharmacol acids in children with developmental coordination disorder.
10:111-117, 2000. Pediatrics 115:1360-1366, 2005.
90. Walsh WD, Glab LB, Haakenson ML: Reduced violent behavior 113. Chen J-R, Hsu S-R, Hsu C-D, et al: Dietary patterns and blood fatty
following biochemical therapy. Physiol Behav 82:835-839, 2004. acid composition in children with attention-deficit hyperactivity
90a. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition disorder in Taiwan. J Nutr Biochem 15:467-472, 2004.
(DSM-IV). Arlington, VA, American Psychiatric Association, 1994. 114. Stoll AL, Severus WE, Freeman MP, et al: Omega-3 fatty acids in
91. Kozielec T, Starobrat-Hermelin B: Assessment of magnesium levels bipolar disorder: A preliminary double-blind, placebo-controlled
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
in children with attention deficit hyperactivity disorder (ADHD). trial. Arch Gen Psychiatry 56:407-412, 1999.
Magnes Res 10:143-148, 1997. 115. Maes M, Smith RS: Fatty acids, cytokines, and major depression.
92. Mousain-Bosc M, Roche M, Rapin J, Bali J-P: Magnesium vitamin Biol Psychiatry 43:313-314, 1998.
B 6 intake reduces central nervous system hyperexcitability in 116. www.nal.usda.gov/fnic/etext/fnic.html and go to Dietary Reference
children. J Am Coll Nutr 23:545S-548S, 2004. Intakes.
93. Nogovitsina OR, Levitina EV: Diagnostic value of examination of 117. www.cfsan.fda.gov/~dms/foodlab.html and see 6.
the magnesium homeostasis in children with attention deficit 118. Barkley RA: Issues in the diagnosis of attention-deficit/hyperactivity
syndrome with hyperactivity. Klinich Lab Diagn 5:17-19, 2005. disorder in children. Brain Dev 25:77-83, 2003.
94. Schlingmann KP, Weber S, Peters M, et al: Hypomagnesemia with 119. Coles R: The Spiritual Life of Children. Boston, Houghton
secondary hypocalcemia is caused by mutations in TRPM6, a new Mifflin, 1991.
member of the TRPM gene family. Nat Genet 3:166-170, 2002. 120. Richter NC: The efficacy of relaxation training with children
95. Starobrat-Hermelin B, Kozielec T: The effects of magnesium [review]. J Abnormal Child Psychol 12:319-344, 1984.
physiological supplementation on hyperactivity in children with 121. Dunn F, Howell RJ: Relaxation training and its relationship to
attention deficit hyperactivity disorder (ADHD): Positive response hyperactivity in boys. J Clin Psychol 38:92-100, 1982.
to magnesium oral loading test. Magnes Res 10:149-156, 1997. 122. Denkowski KM, Denkowski GC: Is group progressive relaxation
96. Carlton RM, Ente G, Blum L, et al: Rational dosages of nutrients training as effective with hyperactive children as individual EMG
have a prolonged effect on learning disabilities. Alt Ther 6: biofeedback treatment? Biofeedback Self-Regul 9:353-364, 1984.
85-91, 2000. 123. Lee SW: Biofeedback as a treatment for childhood hyperactivity:
97. Saugstad LF: From superior adaptation and function to brain A critical review of the literature. Psychol Rep 68:163-192, 1991.
dysfunction: The neglect of epigenetic factors. Nutr Health 18: 124. Nash JK: Treatment of attention deficit hyperactivity disorder with
3-27, 2004. neurotherapy [review]. Clin Electroenceph 31:30-37, 2000.
98. Richardson AJ, Puri BK: The potential role of fatty acids in 125. Jones CB: Parent Articles about ADHD. San Antonio, TX,
attention-deficit/hyperactivity disorder. Prostaglandins Leukot Communication Skill Builders, 1999.
Essent Fatty Acids 63:79-87, 2000. 126. Field T: Massage therapy effects. Am Psychol 53:1270-1281, 1998.